Detalhe da pesquisa
1.
Early intestinal microbial features are associated with CD4 T-cell recovery after allogeneic hematopoietic transplant.
Blood
; 139(18): 2758-2769, 2022 05 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35061893
2.
Interventions and outcomes of adult patients with B-ALL progressing after CD19 chimeric antigen receptor T-cell therapy.
Blood
; 138(7): 531-543, 2021 08 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33851211
3.
Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia.
N Engl J Med
; 378(5): 449-459, 2018 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29385376
4.
Pediatric-inspired chemotherapy incorporating pegaspargase is safe and results in high rates of minimal residual disease negativity in adults up to age 60 with Philadelphia chromosome-negative acute lymphoblastic leukemia.
Haematologica
; 106(8): 2086-2094, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33054114
5.
A simplified CD34+ based preharvest prediction tool for HPC(A) collection.
Transfusion
; 61(5): 1525-1532, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33694175
6.
Evaluation of peripheral blood mononuclear cell collection by leukapheresis.
Transfusion
; 59(5): 1765-1772, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30747437
7.
Comparison of manual hematocrit determinations versus automated methods for hematopoietic progenitor cell apheresis products.
Transfusion
; 56(2): 528-32, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26395285
8.
Evaluation of new automated hematopoietic progenitor cell analysis in the clinical management of peripheral blood stem cell collections.
Transfusion
; 55(8): 2001-9, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25808236
9.
Immune reconstitution, vaccine responses, and rituximab use after ex-vivo CD34-selected myeloablative allogenic hematopoietic cell transplantation.
Bone Marrow Transplant
; 59(5): 625-629, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38351281
10.
Treatment of adults with acute lymphoblastic leukemia: do the specifics of the regimen matter?: Results from a prospective randomized trial.
Cancer
; 119(6): 1186-94, 2013 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23280086
11.
Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias.
Blood
; 118(18): 4817-28, 2011 Nov 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-21849486
12.
Translocation t(11;17) in de novo myelodysplastic syndrome not associated with acute myeloid or acute promyelocytic leukemia.
Acta Haematol
; 129(1): 48-54, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23147462
13.
Vaccination with synthetic analog peptides derived from WT1 oncoprotein induces T-cell responses in patients with complete remission from acute myeloid leukemia.
Blood
; 116(2): 171-9, 2010 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20400682
14.
Prolonged SARS-CoV-2 Infection in Patients with Lymphoid Malignancies.
Cancer Discov
; 12(1): 62-73, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34753749
15.
Treatment of Patients with Acute Myeloid Leukemia with the Targeted Alpha-Particle Nanogenerator Actinium-225-Lintuzumab.
Clin Cancer Res
; 28(10): 2030-2037, 2022 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35247915
16.
Universal Engraftment after Allogeneic Hematopoietic Cell Transplantation Using Cryopreserved CD34-Selected Grafts.
Transplant Cell Ther
; 27(8): 697.e1-697.e5, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33991721
17.
CD8 T cells compensate for impaired humoral immunity in COVID-19 patients with hematologic cancer.
Res Sq
; 2021 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33564756
18.
WT1 peptide vaccinations induce CD4 and CD8 T cell immune responses in patients with mesothelioma and non-small cell lung cancer.
Cancer Immunol Immunother
; 59(10): 1467-79, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20532500
19.
Favorable outcomes of COVID-19 in recipients of hematopoietic cell transplantation.
J Clin Invest
; 130(12): 6656-6667, 2020 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32897885
20.
Tolerability, pharmacodynamics, and pharmacokinetics studies of depsipeptide (romidepsin) in patients with acute myelogenous leukemia or advanced myelodysplastic syndromes.
Clin Cancer Res
; 14(3): 826-32, 2008 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18245545